IntegraMed® Elects Michael C. Howe to Its Board of Directors

PURCHASE, N.Y.--(BUSINESS WIRE)-- IntegraMed America, Inc. (NASDAQ: INMD), the leader in developing, marketing and managing specialty healthcare facilities in the fertility and vein care markets, announced today that its Board of Directors has elected Mr. Michael C. Howe to the Board, effective July 1, 2011. Mr. Howe’s term will expire at IntegraMed’s next annual meeting of stockholders to be held in 2012. Mr. Howe’s appointment expands IntegraMed’s Board to seven Directors.

Mr. Howe is the former CEO of MinuteClinic, the pioneer and leading provider of retail-based health clinics in the U.S. From 2005 to 2008 Mr. Howe led the growth of the business from 19 clinics to 525 clinics, including its successful acquisition by CVS Caremark Corporation in 2006. From 1999 to 2004, Mr. Howe served as CEO of Arby’s, a national fast-food chain. Mr. Howe has also held various senior-level positions at companies including Triarc Restaurant Group, PepsiCo and Procter & Gamble. He earned his Bachelor’s degrees in Business Administration and Accounting from the University of Minnesota Duluth. Since 2008, Mr. Howe has been the principal of Howe Associates, a management consulting company in Minneapolis.

"We are extremely fortunate to have Michael join the IntegraMed Board," said Jay Higham, IntegraMed Chairman and CEO. "Michael brings a tremendous record of achievement in leading and growing retail healthcare and consumer oriented businesses, experience that is extremely relevant to our growth goals. His deep understanding of healthcare and strong leadership skills will also complement our Board’s leadership. I look forward to the benefit of Michael’s counsel as we continue our work in expanding and improving our business.”

There are no prior arrangements or understandings between Mr. Howe, and any other person regarding Mr. Howe’s election to the Board. The Board has not made any determinations yet regarding which committees of the Board, if any, to which Mr. Howe will be appointed. Mr. Howe’s compensation as a Board member will be in accordance with the standard Board compensation arrangement set forth in IntegraMed’s proxy statement filed with the SEC on April 20, 2011.

About IntegraMed America, Inc.

IntegraMed is a leader in developing, marketing and managing specialty outpatient healthcare facilities, with a current focus on the fertility and vein care markets. IntegraMed supports its provider networks with clinical and business information systems, marketing and sales, facilities and operations management, finance and accounting, human resources, legal, risk management, quality assurance, and fertility treatment financing programs.

Attain Fertility Centers, an IntegraMed Specialty, is the nation’s largest fertility center network, with 14 company-managed partner centers and 28 affiliate centers, comprising over 130 locations across 34 states and the District of Columbia. Nearly one of every four IVF procedures in the U.S. is performed in an Attain Fertility Centers network practice.

Vein Clinics of America, an IntegraMed Specialty, is the leading provider of specialty vein care services in the U.S. The IntegraMed Vein Clinic network operates 44 centers across 14 states, principally in the Midwest and Southeast.

For more information about IntegraMed please visit: www.integramed.com for investor background, www.attainfertility.com for fertility, or www.veinclinics.com for vein care.

Statements contained in this press release that are not based on historical fact, including statements concerning future results, performance, expectations and expansion of IntegraMed are forward-looking statements that may involve a number of risks and uncertainties. Actual results may differ materially from the statements made as a result of various factors, including, but not limited to, the risks associated with IntegraMed's ability to identify, consummate and finance future growth, changes in insurance coverage, government laws and regulations regarding health care or managed care contracting; and other risks, including those identified in the company's most recent Form 10-K and in other documents filed by IntegraMed with the U.S. Securities and Exchange Commission. All information in this press release is as of June 30, 2011 and IntegraMed undertakes no duty to update this information.

Jaffoni & CollinsNorberto Aja, David Collins212-835-8500 or [email protected]

Source: IntegraMed America, Inc.